Vaccine

Article	Citations
Syncope after live attenuated influenza vaccine: Reports to the Vaccine Adverse Event Reporting System (2003–2024)	272
Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom	172
Quantitation and characterization of serotype 6A activation for pneumococcal conjugate vaccine by cryo-EM and SEC methods	161
COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants	121
“Fighting the pandemic!” Western Australian pharmacists’ perspectives on COVID-19 vaccines: A qualitative study	117
Humoral immune response profile of a cattle herd vaccinated with 5- and 10-times Bakirköy strain sheep pox vaccine under field conditions	115
Evaluating concurrency and gaps between self-report and vaccine card data for COVID-19 vaccination	110
Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination	93
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates	93
Erratum to “Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals” [Vaccine 41(37) (2023) 5469-5476]	90
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom	88
BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study	85
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study	85
Compliance, procrastination and refusal: American COVID-19 vaccination trust and value orientation	82
The social lives of the SARS-CoV-2 vaccines: A qualitative study of vaccine understandings and decision-making among people of Black ethnicities in London, UK	81
Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS coloni	81
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental chal	79
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics	75
Letter to the editor: SARS-CoV-2 vaccination in children and adolescents with neurodevelopmental or psychiatric disorders	72
Nationwide rollout of HPV vaccination in Nepal: Early key insights	72
Assessing commutability of the first WHO International Standard for antiserum to respiratory syncytial virus	72
Timeliness and completeness of serial routine vaccinations among 8062 rural children in southwest China during the COVID-19 pandemic: A multi-stage stratified cluster sampling survey in 1094 villages	72
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study	70
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine	69
Editorial Board/Aims and Scope	67

Editorial Board/Aims and Scope	63
TAK − 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice	62
Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus	60
Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the process	60
Vaccination during febrile illness, what do we know? A systematic-narrative hybrid review of the literature and international recommendations	58
Systematic review of pro-equity strategies to improve vaccination among priority populations	57
Humoral and cellular immune responses induced by serogroup W135 meningococcal conjugate and polysaccharide vaccines	56
The Brucella abortus A19ΔfeuPΔfeuQ double-mutant is highly attenuated and confers protection in BALB/c mice	56
Long-term impact of rotavirus vaccination on all-cause and rotavirus-specific gastroenteritis and strain distribution in Central Kenya: An 11-year interrupted time-series analysis	56
U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic	55
Erratum to “Motivational interviewing and vaccine acceptance in children: The MOTIVE study” [Vaccine 40(12) (2022) 1846–1854]	55
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)	53
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink	53
Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season	52
Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents	51
Herpes zoster mRNA vaccine elicits superior immune responses over licensed vaccines with a favorable safety profile in animal models	51
Effectiveness of the varicella vaccine in the real world, a matched case-control study	49
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys	49
Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants	48
Advancing the use of vaccine impact modeling for immunization decisions in low- and middle-income countries	46
Safety monitoring of health outcomes following influenza vaccination during the 2023–2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series	45
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up	45
Examining the independent and interactive roles of intolerance of uncertainty in vaccination intent	45
Racial and ethnic differences among Mpox vaccination recipients by vaccination facility type in New York City—August–December 2022	44
A decade of rotavirus vaccination in the World Health Organization African Region: An in-depth analysis of vaccine coverage from 2012 to 2023	43
A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding women	43
Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea	42
Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study	42
Knowledge, attitudes, and practices of healthcare providers regarding vaccinating children with cancer in Latin America and the Caribbean	42
Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children	41
Identification of T-cell epitopes of the intracellular parasite Babesia bovis by immunopeptidomic analysis of BoLA-II presented peptides	41
Corrigendum to ‘Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice’ [Vaccine 39 (2021) 6213–6220]	40
Corrigendum to “Recombinant BCGΔBCG1419c protects outbred mice against M. tuberculosis challenge” [Vaccine 61 (2025) 127347]	40
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis	40
Healthcare professional and professional stakeholders’ perspectives on vaccine mandates in Switzerland: A mixed-methods study	39
Corrigendum to “Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis” [Vaccine 40(41) (2022) 5971	39
Corrigendum to “I want to chat with a person”: a qualitative longitudinal cohort study in England exploring drivers of sub-optimal childhood vaccination uptake” [Vaccine 62 (2025) 127462]	39
Integrating the person-centered approach with the study of vaccine hesitancy: Applying latent profile analysis to identify vaccine hesitancy subpopulations and assess their relations with correlates a	38
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic	38
Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008–2019	38
UK healthcare professionals’ attitudes towards the introduction of varicella vaccine into the routine childhood vaccination schedule and their preferences for administration	38
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria	37
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysacchar	37
Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh	37
Pneumococcal vaccines: A dose of change. Vaccine failures and breakthrough infections in Belgian children during the PCV13 era (2019–2024)	37
Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2	37
COVID-19 vaccine production and the technological gap in the Global South: The cases of Argentina and Brazil	37
A scoping review of multicomponent interventions to improve uptake of routine childhood vaccines in low- and middle-income countries	37
Dynamics of global emergency vaccine stockpiles: A systems analysis and application to cholera	37
Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010	36

Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels	36
A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein	36
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate	36
The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs	36
Differences in influenza vaccine effectiveness by sex among adults hospitalized with acute respiratory illness—IVY network, January 24, 2022–September 1, 2024	35
Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling	35
Corrigendum to “A cost-effectiveness analysis of South Africa's COVID-19 vaccination programme” [Vaccine 42(20) (2024) 125988	35
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants	35
Determinants of immunization in polio super high-risk union councils of Pakistan	34
The U.S. COVID-19 vaccination program: A look back and future directions	34
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation	34
Characteristics of reported mumps cases in the United States: 2018–2023	34
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic	34
A new method for testing avian metapneumovirus vaccine efficacy: Evaluation of tracheal ciliary activity after a challenge	34
Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate	33
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the fi	33
Analysis of HPV vaccination and influencing factors among 9–14-year-old girls in underdeveloped areas of northwestern China: A cross-sectional survey report on guardians	33
Vaccine misinformation among Arabic-speakers in Australia and the audience and appetite for a game-based intervention	33
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-con	33
Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate	33
HPV vaccination acceptance and perceptions related to fertility and population control in the Gambia: An anthropological analysis	33
Assessing the potential impact of the 20-valent (PCV20) and an adult 21-valent (aPCV21) pneumococcal conjugate vaccine on invasive pneumococcal disease in England	33
Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework	33
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States	33
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines	33
Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states	33
Assessing vaccination intentions and perceptions among pregnant women in Italy: A multicenter cross-sectional study in the context of mandatory policies and the COVID-19 pandemic	32
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort	32
The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies	32
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations	32
Weaving a public health network: Process and results from an evaluation of CDC’s Prevention Research Centers Vaccine Confidence Network	32
Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England	32
Pneumonia hospitalization after introduction of pneumococcal conjugate vaccine in Japan: Descriptive study using a nationwide claims database	32
Waning of measles immunity by 5 years of age following an accelerated two-dose measles vaccine schedule at 6 and 12 months in South African children: an observational cohort study	32
COVID-19 and seasonal influenza: The potential 2021–22 “Twindemic”	32
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults	32
Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2	32
Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019	32
Use of an adapted participatory learning and action cycle to increase knowledge and uptake of child vaccination in internally displaced persons camps (IVACS): A cluster-randomised controlled trial	31
Genetic markers of enhanced functional antibody responses to COVID-19 vaccination	31
Collateral damage from debunking mRNA vaccine misinformation	31
Multi-mode spatial accessibility to vaccination services and its impact on influenza-related hospitalisations among older adults	31
Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus	31
Measles seroprevalence among individuals serologically tested in Ontario, Canada	31
Corrigendum to ‘A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older’ Vac	30
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years an	30
Social and demographic patterns of influenza vaccination coverage in Norway, influenza seasons 2014/15 to 2020/21	30
“Every interaction you have …should be an opportunity to discuss and offer influenza vaccination”. Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families li	30
State minor consent laws and human papilloma virus vaccine uptake: An analysis of the 2023 National Immunization Survey-Teen Data	30
Exposure to objective/sensationalist information moderates associations between psychological factors and COVID-19 anti-vaccination attitudes: An experimental study	30
IFITM3-deficient mice as a model for testing influenza virus vaccines via the intramuscular route	30
A modified self-controlled case series on mortality risk following primary series doses of COVID-19 vaccines in U.S. Medicare beneficiaries aged 65 years and older	30
A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which correlate with anti HBs antibody titers: An investigation into the immunological mechanisms contributing to high anti-HBs t	30
Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo	29
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine	29
Editorial Board	29
Public health impact and cost-effectiveness of implementing a ‘pre-vaccination screening' strategy with the dengue vaccine in Puerto Rico	29
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers	29
How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects?	29
Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia	29
Safety and 6-month immune persistence of inactivated poliovirus vaccine (Sabin strains) simultaneously administrated with other vaccines for primary and booster immunization in Jiangxi Province, China	28
“EvoVax” – A rationally designed inactivated Salmonella Typhimurium vaccine induces strong and long-lasting immune responses in pigs	28
How manufacturing won or lost the COVID-19 vaccine race	28
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study	28
Genetic and molecular basis for low efficacy of vaccine strains against canine distemper virus in Brazil	28
Adaptive immune response to a wild boar-derived recombinant hepatitis e virus capsid protein challenge in pigs	28
Vaccine value profile for Salmonella enterica serovar Paratyphi A	28
COVID-19 vaccine attitudes, beliefs, intentions and behaviors among pregnant women within the context of dynamic national policy recommendations in Brazil, Ghana, Kenya, and Pakistan	28
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization R	28
Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster	28
Strategies to improve interprofessional communication regarding maternal and infant RSV immunization	28
County-level correlates of completed HPV vaccination in Indiana	27
Determinants of COVID-19 vaccine hesitancy and resistance in Russia	27
Social and demographic factors associated with receipt of a COVID-19 vaccine initial booster dose and with interval between primary series completion and initial booster dose uptake among persons aged	27
Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles	27
Potential benefits of optimised varicella vaccination scenarios in a western Chinese province: a modelling study using real-world data	27
Influenza vaccination status ascertainment and vaccine effectiveness estimation: Validity of self-report for current and prior season	27
Evaluation of Rift Valley fever vaccine candidates in pregnant rodent models	27
Factors affecting human papillomavirus vaccination: A review of individual, interpersonal, and structural factors affecting vaccine uptake among adolescents	27
Seroprotection against tetanus in the Italian general population	26

New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Quebec, Canada	26
Safe and efficacious inactivated immersion vaccine against KG+ phenotype of emerging bacterial pathogen Lactococcus garvieae for early developmental stage of rainbow trout (Oncorhynchus mykiss) in Ind	26
Analyzing attitudes toward COVID-19 vaccine decision making among pregnant women in Pakistan	26
Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community	26
Harmonized case definitions for endpoints in vaccine efficacy trials are needed	26
The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students	26
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022	26
Understanding parental HPV vaccination decision in China through the lens of vaccine hesitancy and preference heterogeneity: a discrete choice experiment	26
Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection	26
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study	26
Using latent class analysis of survey data to explore parent behaviors and attitudes regarding children's COVID vaccinations	25
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers	25
Editorial Board/Aims and Scope	25
Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh	25
Engineered flagellin-based adjuvant boosts mucosal immunity in recombinant RSV vaccine	25
Editorial Board	25
Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents	25
The shadow of reactogenicity: Parental hesitancy due to prior vaccine experiences	25
Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008–2018)	25
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design	25
Editorial Board/Aims and Scope	24
Changes in depressive symptoms and antibody production following influenza vaccination in adolescents and adults	24
A novel high throughput plate-based method for 2-PE quantification in novel multidose vaccines (R21 malaria, Covishield and Covovax) and combination vaccines (Hexavalent)	24
Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate	24
Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019–2020	24
Mumps virus neurovirulence assessment-impact of viral doses, animal sex and age on results dispersion	24
Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health	24
Editorial Board/Aims and Scope	24
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients	24
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial	24
Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18–24 Months: A phase Ⅳ clinical trial	24
Vaccination patterns and up-to-date status of children 19–35 months, 2011–2021	24
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET	24
Need for a contingency dimension when planning vaccine development in a pandemic environment	24
Crowdfunding narratives and the valuation of vaccines for COVID-19	24
Evaluation of anti-Pertussis antibody levels in Iranian infants and children: Is it time to include booster acellular Pertussis Vaccines in the immunization schedule?	24
Enhancing NA immunogenicity through novel VLP designs.	23
Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study	23
Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks	23
Construction of a Lactobacillus plantarum-based claudin-3 targeting delivery system for the development of vaccines against Eimeria tenella	23
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan	23
Vaccine candidate based on a baculovirus expressed VP2 provides full protection from epizootic hemorrhagic disease virus serotype 8 in calves	23
Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens	23
Assessing effects of pneumococcal vaccination (PCV13) and rotavirus vaccination (RV) on colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in Guatemalan children	23
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection	23
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022	23
COVID-19 hoax belief endorsement and its implications for vaccine uptake: Investigating the role of perceived threat	23
Drivers of decision-making for future adult vaccines: a best–worst scaling among community members and health care workers in Zambia	23
“COVID is a huge jigsaw puzzle that I am trying to make sense of myself”: Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adu	23
HPV vaccination coverage and determinants in adolescent girls with disability: a scoping review	23
Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer	23
The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) S	23
Vaccines against Neisseria meningitidis serogroup B strains – What does genomics reveal on the Portuguese strain’s coverage	23
Increasing vaccination coverage among healthcare workers: Active call and mandatory laws. Data from a large general hospital in Southern Italy	22
Staff and caregivers' perceptions of digital storytelling to increase influenza vaccine confidence in an urban safety-net healthcare system	22
Accuracy of self-reported vaccination status using surveys in safety-net, integrated and rural health systems in Colorado	22
The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III	22
Factors associated with vaccination intention and uptake over time in a sample of older Australians	22
A phase 3 randomized trial (STRIDE-9) to evaluate the safety, tolerability, and immunogenicity of V116, a population-specific pneumococcal conjugate vaccine, in pneumococcal vaccine-naïve Japanese adu	22
Associations between family planning, healthcare access, and female education and vaccination among under-immunized children	22
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic	22
Weighing the risks and benefits: Parental perspectives on COVID-19 vaccines for 5- to 11-year-old children	22
Corrigendum to, “Attitudes and beliefs of healthcare providers toward vaccination in the United States: A cross-sectional online survey” [Vaccine (2024) Dec 2 42(26) 126437]	22
Comparison of SARS-CoV-2 antibody responses following the second dose of BNT162b2 and mRNA-1273 vaccines in people living with HIV-1	22
Impact of the surge of COVID-19 Omicron outbreak on the intention of seasonal influenza vaccination in Hong Kong: A cross-sectional study	22
Persistence of immunity in children aged 2 months and 7 months – 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine	22
Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-s	22
Comparison of performance of varicella vaccines via infectious disease modeling	22
COVID-19 vaccine decision-making among Black women: A qualitative study	22
Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis	22
Corrigendum to “Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III tria	22
Single immunization of non-adjuvanted recombinant TTFC-mi3 nanoparticle vaccine elicited a rapid and potent protective immunity against tetanus	22
Corrigendum to “Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurell	22
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targets	22
In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine	21
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development	21
High prevalence of human papillomavirus (HPV) in unvaccinated adolescent girls in South Africa, particularly those living with HIV	21
Erratum to “Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with down syndrome” [Vaccine 73 (2026) 128079]	21
Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain	21
Consultation report – considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries	21
Preliminary safety evaluation of a diphtheria, tetanus, acellular component pertussis, Sabin inactivated poliovirus and Haemophilus influenzae type b combination vaccine (DTacP-sIPV/Hib)	21
The impact of COVID-19 childhood and adolescent vaccination on mortality in Argentina	21
Applying the COM-B behaviour model to understand factors which impact school immunisation nurses’ attitudes towards designing and delivering a HPV educational intervention in post-primary schools for	21
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023	21
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study	21
Barriers and facilitators associated with migrant parents' decisions regarding childhood vaccinations: A mixed methods systematic review	21
Intent to receive flu vaccine and influenza vaccination coverage among health professionals during 2019, 2020 and 2021 campaigns in Côte d’Ivoire	21
Effective mRNA-based therapy using E7 antigen and IL-12 cytokine in head and neck cancer mice models	21
Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan	21
Post-vaccination fever in infants: Real-world data analysis using a childcare mobile application	21
Advancing typhoid conjugate vaccine implementation in Asia: Regional policy priorities	21
Nanoparticles displaying fHbp elicit an enhanced antibody response against meningococcal B isolates compared to low valency fHbp antigens	21
Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccine uptake among pregnant women (EPIC study) in Australia	21
ACE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation	21
Analysis of health claims data on vaccination coverage in older adults in Bavaria, Germany: Influenza, pneumococcus and herpes zoster	21